QT Imaging Holdings, Inc. (QTI)
| Market Cap | 68.15M +1,124.5% |
| Revenue (ttm) | 11.50M +184.8% |
| Net Income | -23.18M |
| EPS | -2.57 |
| Shares Out | 11.92M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,180 |
| Open | 5.51 |
| Previous Close | 5.61 |
| Day's Range | 5.30 - 5.72 |
| 52-Week Range | 0.97 - 9.21 |
| Beta | -0.10 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 31, 2025 |
About QTI
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, monitoring, and treatment of diseases in the United States and Internationally. The company offers QT Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. It serves patients, medical professionals, and radiologists. QT Imaging Holdings, Inc. was founded in 2012 and is headquartered in Novato, California.
Financial Performance
In 2024, QT Imaging Holdings's revenue was $4.88 million, an increase of 11989.37% compared to the previous year's $40,355. Losses were -$14.17 million, 132.3% more than in 2023.
Financial StatementsNews
QT Imaging Announces Presentation at SPIE Medical Imaging 2026
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative...